Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/2008
10/29/2008CN101293888A Xanthine derivative, production and use thereof as a medicament
10/29/2008CN101292958A Method of preparing ultra-fine danazol powder
10/29/2008CN101292740A Biological food for accelerating sex hormone secretion in vivo
10/29/2008CN100429210C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
10/29/2008CN100428959C Process for producing drug ultramicroparticle and apparatus therefor
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442807 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
10/28/2008US7442546 Method of modulating inflammatory response
10/23/2008WO2008128086A1 Ranolazine for enhancing insulin secretion
10/23/2008WO2008126752A1 Skin-lightening agent containing equol compound as active ingredient
10/23/2008WO2008124922A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
10/23/2008WO2008075162A3 Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
10/23/2008WO2007117438A3 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
10/23/2008WO2007062093A3 Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
10/23/2008US20080262005 Uracil-Type Gonadotropin-Releasing Hormone Receptor Antagonists and Methods Related Thereto
10/23/2008US20080261951 Condensed azepines as vasopressin agonists
10/23/2008US20080261937 Pharmaceutical compositions and method for treating pediatric hypogonadism
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008CA2683522A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
10/23/2008CA2681444A1 Ranolazine for enhancing insulin secretion
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1982981A1 Process for production of lasofoxifene or analogue thereof
10/22/2008EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents
10/22/2008EP1326631B2 Botulinumtoxin for treating endocrine disorders
10/22/2008CN101291950A 新系列咪唑基取代的类固醇和茚满-1-酮衍生物 New series of imidazolyl substituted steroidal and indan-1-one derivative
10/22/2008CN101291682A Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts
10/22/2008CN101291677A Combination of a silicon containing component and a hormone
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN101289408A Non-steroid progestogen receptor regulator, preparation thereof, pharmaceutical compositions and uses
10/22/2008CN101288740A Chinese medicine for treating primary adrenal cortical hypofunction
10/22/2008CN101288721A Chinese medicinal composition for treating hypothyroidism and its preparation method
10/22/2008CN101288660A Levonorgestrel drop pills and preparation method thereof
10/22/2008CN100427077C Dry powder inhalation system for transpulmonary administration
10/21/2008US7439248 5-[[4-[3-Methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenyl-methyl]thiazolidine-2,4-dione or salt; compressed tablets; microcrystalline cellulose, magnesium stearate, lactose, or talc excipients; antidiabetic agents for non-insulin dependent diabetes; insulin sensitizers
10/16/2008WO2008124000A2 Thiazole derivatives as androgen receptor modulator compounds
10/16/2008WO2008122667A2 Ureylene derivatives
10/16/2008WO2008122510A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
10/16/2008US20080255198 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide
10/16/2008US20080254154 Comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; climacteric disturbance, primary hypogonadism (including ovarian hypofunction and testicular deficiency), Turner's syndrome, Klinefelter's syndrome, gonadotropin-producing tumor, testitis, ovarian amenorrhea
10/16/2008US20080254127 Inhalation particles incorporating a combination of two or more active ingredients
10/16/2008CA2682287A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
10/15/2008EP1980249A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2008EP1980247A1 Growth hormone secretion regulator
10/15/2008EP1978950A2 Pharmaceutical sustained release compositions comrising in particular thyroid hormones
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1406649B9 Use of substances with oxytocin activity against climacteric disorders
10/15/2008EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders
10/15/2008CN101287461A Use of 5-amido-1h-pyrrole-2-nitrile derivative as progesterone receptor modulators
10/15/2008CN101284795A Non-steroidal male hormone receptor regulating agent and medical uses thereof
10/15/2008CN101284096A Sheep placenta capsule compound nest-defence capsule for beautifying face
10/15/2008CN101284053A Multifunctional compound medicine formulation
10/15/2008CN100425608C Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/15/2008CN100425592C Indole derivatives
10/15/2008CN100425284C Methods for glucagon suppression
10/15/2008CN100425239C Therapeutic applications of 2-substituted 4-heteroarylpyrimidines
10/15/2008CN100425230C Use of flavone substance or triterpene compound for treating thyreoidism
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008US7435720 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
10/14/2008CA2379995C 11.beta.-aryl-17,17-spirothiolane-substituted steroids
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008119918A1 Mineralocorticoid receptor antagonists
10/09/2008WO2008119744A1 Heterocyclic spiro-compounds
10/09/2008WO2008119130A1 Herbal compositions and methods for treating premenstrual syndrome
10/09/2008US20080249183 Treatment of androgen-deprivation induced osteoporosis
10/09/2008US20080248069 Dosage Forms of Active Ingredients Containing Hydroxystilbene for Treating Menopausal Complaints
10/09/2008US20080247994 DNA vaccine
10/09/2008CA2701638A1 Pharmaceutical calcimimetics
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2681978A1 Heterocyclic spiro-compounds
10/09/2008CA2681935A1 Treatment of obesity
10/09/2008CA2680533A1 Mineralocorticoid receptor antagonists
10/08/2008EP1881830B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
10/08/2008EP1824863B1 Silicon compounds and their use
10/08/2008EP1499360B1 Formulation comprising buprenorphine
10/08/2008EP1064298B1 Inhibitors of caspases
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008CN101282987A Glucocorticoid 16alpha,17alpha-isoxazolidines as anti-inflammatory agents
10/08/2008CN101279031A Chinese medicinal composition for curing hyperthyroidism and method of preparing the same
10/08/2008CN100424078C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
10/08/2008CN100423777C Glycoprotein compositions
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
10/07/2008US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas
10/07/2008US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent
10/07/2008US7432067 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility
10/07/2008US7431941 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances
10/07/2008CA2259532C Transdermal drug delivery matrix for coadministering estradiol and another steroid
10/07/2008CA2106061C Human follicle stimulating hormone receptor
10/02/2008WO2008117814A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008WO2008116671A1 2,3,4,9-tetrahydro-1h-carbazoles
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 290